Home /Research /A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy

OTHER

A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy

Heather L. McArthur, Elizabeth Comen, Yolanda Bryce, Stephen B. Solomon, J.H.S. Leal, Micaela Rodine, Christina DiLauro Abaya, Sujata Patil, David B. Page, Larry Norton

Year: 2019
Citations: 2

Keywords

MedicineCryoablationStandard of careStage (stratigraphy)ChemotherapyNeoadjuvant therapyIpilimumabOncologyBreast cancerInternal medicine

A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy

Keywords

Related papers

Statistical Learning Theory

Fractional Differential Equations

Applied Nonlinear Control

Genetic Programming: On the Programming of Computers by Means of Natural Selection